Assignee
CLEXIO BIOSCIENCES LTD
IL·36 granted patents·33 pending applications·89 citations·filing 2015–2025
Top patents by PatentIndex Score
69 records- 0196US11534409B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 27, 2022·4 cites·19 claims
- 0295US11253487B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Feb 22, 2022·14 cites·20 claims
- 0394US12016832B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2022·Granted Jun 25, 2024·5 cites·20 claims
- 0494US11957645B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Apr 16, 2024·4 cites·17 claims
- 0594US11207318B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Dec 28, 2021·3 cites·14 claims
- 0692US11865088B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jan 9, 2024·4 cites·17 claims
- 0792US11730702B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Aug 22, 2023·2 cites·20 claims
- 0891US11903928B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Feb 20, 2024·2 cites·20 claims
- 0991US10888528B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jan 12, 2021·3 cites·19 claims
- 1091US10568881B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Feb 25, 2020·7 cites·23 claims
- 1191US10195143B2Devices and methods for preparing gastroretentive dosage formsCLEXIO BIOSCIENCES LTD·Filed 2016·Granted Feb 5, 2019·9 cites·26 claims
- 1290US11185532B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Nov 30, 2021·3 cites·20 claims
- 1389US10485758B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2015·Granted Nov 26, 2019·11 cites·62 claims
- 1487US11324707B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2020·Granted May 10, 2022·3 cites·19 claims
- 1587US11147766B2Gastric retentive devicesCLEXIO BIOSCIENCES LTD·Filed 2016·Granted Oct 19, 2021·4 cites·20 claims
- 1685US12336970B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·16 claims
- 1785US12280022B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 1885US12076300B2Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Sep 3, 2024·1 cites·5 claims
- 1984US12514831B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Jan 6, 2026·0 cites·9 claims
- 2084US12268658B2Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Apr 8, 2025·2 cites·19 claims
- 2184US11285102B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Mar 29, 2022·1 cites·19 claims
- 2284US2023293445A1Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 2384US2026021058A1Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2483US2025281428A1Method Of Treating Major Depressive DisorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2581US12239634B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Mar 4, 2025·0 cites·20 claims
- 2680US12036189B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jul 16, 2024·3 cites·17 claims
- 2780US11844796B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 19, 2023·0 cites·17 claims
- 2879US2025195454A1Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2978US2026053757A1Dosage regime with esketamine for treating neuropsychiatric or neurological conditionsCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 3076US2022202709A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3175US2022160630A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3275US2022211617A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3375US2025312293A1Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 3474US11547839B2Long acting gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Jan 10, 2023·2 cites·10 claims
- 3574US10737079B2Gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2017·Granted Aug 11, 2020·2 cites·37 claims
- 3673US2022202708A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3772US11648198B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2020·Granted May 16, 2023·0 cites·15 claims
- 3872US2024374539A1Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 3971US12364672B2Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jul 22, 2025·0 cites·15 claims
- 4070US11992468B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2023·Granted May 28, 2024·0 cites·8 claims
- 4169US11964120B2Long acting gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2022·Granted Apr 23, 2024·0 cites·12 claims
- 4268US12589083B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Mar 31, 2026·0 cites·11 claims
- 4368US2022370347A1Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's diseaseCLEXIO BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4467US2024366530A1Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4565US12478592B2Dosage regime with esketamine for treating neuropsychiatric or neurological conditionsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Nov 25, 2025·0 cites·16 claims
- 4665US10406154B2Transdermal dosage formCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Sep 10, 2019·0 cites·27 claims
- 4765US2023398098A1Topical detomidine formulationsCLEXIO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4865US2023080008A1Gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4964US2025082587A1Method Of Treating Major Depressive DisorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 5064US2019343830A1Transdermal dosage formCLEXIO BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CLEXIO BIOSCIENCES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →